PulseAugur
EN
LIVE 02:13:36

AI medical chatbot OpenEvidence valued at $15B amid accuracy concerns

By PulseAugur Editorial · [1 sources] ·

OpenEvidence, an AI chatbot utilized by a significant majority of US physicians, has achieved a valuation of $15 billion following a $250 million funding round. The platform processes approximately 42 million prompts monthly. However, its accuracy has been called into question, with a Nature study indicating that it performed worse than Gemini and GPT on clinical assessments. AI

IMPACT This funding and valuation highlight significant investment in AI for healthcare, though accuracy concerns may temper widespread adoption.

RANK_REASON Significant funding round and valuation for an AI company. [lever_c_demoted from significant: ic=1 ai=0.7]

Read on Mastodon — fosstodon.org →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

AI medical chatbot OpenEvidence valued at $15B amid accuracy concerns

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Research
Significant funding round and valuation for an AI company. [lever_c_demoted from significant: ic=1 ai=0.7]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
funding, product, opinion
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
High
Clearly on-topic for AI-industry coverage.
Story freshness
20 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. Mastodon — fosstodon.org TIER_1 English(EN) · [email protected] ·

    OpenEvidence, the ad-funded medical AI chatbot now used by nearly two-thirds of US doctors, has reached a 15B USD valuation after raising 250M USD in September,

    OpenEvidence, the ad-funded medical AI chatbot now used by nearly two-thirds of US doctors, has reached a 15B USD valuation after raising 250M USD in September, with 42 million prompts processed in a month. Researchers question its accuracy: a Nature paper found it underperformed…

    LINKS arstechnica.com/…/the-15-billion-ad-power…

RELATED ENTITIES

RELATED TOPICS